Drug Suspension Development for the Back of the Eye

Abstract

}s CG , Be ll WJ, O ' Rou rkc p, Knupcr K, Sherma n S, S tabila p, Tao W (2004) .su stained secre· In o f (,.'iliary neurotroph ic fa clor 10 the vi treous, using the e ncapsulated cel l tlll.:rapy-hased r -50! Intraoc ular devi ce . Ti ssue Eng 10 : 161 7-1622 ; GH (199X) Mechanisms of cell death in the inherited retlllal degenera ti o ns, Am J Hum ~ net 6 2: S0~ -50R ntides Sc. Rajmak P. Pham D . Hunke WA , Placek J. Reynolds SD (2004) Fn!e 7,e drying -IOdples and practice for successful sc al e-up [ 0 manufacturi ng. In[ J Pha rm 280 : 1-16 esc FM (200 1) Pepti de a nd prolein PEG ylm ion: a rcv iew of [lmhlem s nnd so luti o ns. o matcrial s 22:405-4 17 ese FM. Mero A (2008) The Impact of PEGylalion o n hio logical Ih erapH.!s, BioDrugs :) 15-)29 esc FM , Sacca B, Pn lvt:rino de Laurclo P. Serg i M, Caliceli p, Schiavon O. Orsolini P (2001) !w PEG s for peptide and protein moditication . sui tahl e ror ide ntification o f the PEG y latio n e . RioconJug Chem 12: 62-70 JH , Tam Sc. Huang H, Ou yang DY, Wa ng YY. Zhcng YT (2004) Site-directed PEGylatio n trich(lsanthin retained it s anli -HIV activity with reduced pote ncy in vi tro. Biochem Siophys ~s Conlin un ~ 17:965 -971 ~rt G. M ichels S. Sacu S. Varga A. Pra ger F. Geitzen